Patterns of Immunohistochemical Expression of P53, BCL2, PTEN, and HER2/neu Tumor Markers in Specific Breast Cancer Lesions

Table 3

Distribution of diagnosis by P53 and BCL2 immunohistochemical expression.

Lesion type	P53		Total	BCL2		Total
	−Ve	+ve		−Ve	+ve
Benign lesions	20	0	20	0	0	0
Carcinoma SBR	1	0	1	0	1	1
Infiltrating DC	39	8	47	38	9	47
Invasive DC	103	30	133	120	13	133
RICA	2	0	2	2	0	2
Intracystic carcinoma	1	0	1	1	0	1
DC in situ	1	2	3	3	0	3
MDFC	1	1	2	2	0	2
PDFC	1	1	2	2	0	2
MANS	1	0	1	1	0	1
Metastatic DC	2	0	2	2	0	2
Invasive LC	8	0	8	7	1	8
Total	180	42	222	178	24	202